[go: up one dir, main page]

ATE386986T1 - Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten - Google Patents

Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten

Info

Publication number
ATE386986T1
ATE386986T1 AT02749828T AT02749828T ATE386986T1 AT E386986 T1 ATE386986 T1 AT E386986T1 AT 02749828 T AT02749828 T AT 02749828T AT 02749828 T AT02749828 T AT 02749828T AT E386986 T1 ATE386986 T1 AT E386986T1
Authority
AT
Austria
Prior art keywords
metabolites
methods
interpret
generate
view
Prior art date
Application number
AT02749828T
Other languages
English (en)
Inventor
Steven Watkins
Original Assignee
Lipomics Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23173313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE386986(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lipomics Technologies Inc filed Critical Lipomics Technologies Inc
Application granted granted Critical
Publication of ATE386986T1 publication Critical patent/ATE386986T1/de

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Bioethics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Artificial Intelligence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT02749828T 2001-07-06 2002-07-05 Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten ATE386986T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370401P 2001-07-06 2001-07-06

Publications (1)

Publication Number Publication Date
ATE386986T1 true ATE386986T1 (de) 2008-03-15

Family

ID=23173313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02749828T ATE386986T1 (de) 2001-07-06 2002-07-05 Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten

Country Status (7)

Country Link
US (2) US20040143461A1 (de)
EP (1) EP1417629B1 (de)
AT (1) ATE386986T1 (de)
AU (1) AU2002320316A1 (de)
CA (1) CA2452660A1 (de)
DE (1) DE60225145D1 (de)
WO (1) WO2003005628A2 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2298181C (en) 2000-02-02 2006-09-19 Dayan Burke Goodnough Non-targeted complex sample analysis
DK1438420T3 (da) * 2001-09-24 2010-01-18 Lipomics Technologies Inc Fremgangsmåder til anvendelse af kvantitative lipid-metablom-data
AU2003225726A1 (en) * 2002-03-11 2003-09-29 Lipomics Technologies, Inc. Novel metabolic targets and markers
US7714398B2 (en) * 2002-09-05 2010-05-11 Nanomix, Inc. Nanoelectronic measurement system for physiologic gases and improved nanosensor for carbon dioxide
US7348143B2 (en) 2002-03-22 2008-03-25 Phenmenome Discoveries Inc. Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
US8346482B2 (en) 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
EP1789806A2 (de) * 2004-09-13 2007-05-30 Lipomics Technologies, Inc. Metabolitmarkierer zur gewichtsverwaltung
WO2006069268A1 (en) * 2004-12-22 2006-06-29 Pharmacyclics, Inc. System and method for analysis of neurological condition
KR100616611B1 (ko) 2005-03-31 2006-08-25 한국과학기술원 Ｘｍｌ을 이용한 대사흐름분석용 정보 시스템 및 그운용방법
CA2608965C (en) 2005-06-30 2014-08-19 Biocrates Life Sciences Ag Device for quantitative analysis of a metabolite profile
US7949475B2 (en) * 2005-08-08 2011-05-24 Metabolon Inc. System and method for analyzing metabolomic data
CA2619732C (en) 2005-09-12 2012-06-12 Phenomenome Discoveries Inc. Methods for the diagnosis of colorectal cancer and ovarian cancer health states
US8637321B2 (en) * 2005-10-24 2014-01-28 Duke University Lipidomics approaches for central nervous system disorders
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7491504B2 (en) 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US20070162992A1 (en) * 2006-01-09 2007-07-12 Mcgill University Metabolomic determination in assisted reproductive technology
US7291502B2 (en) * 2006-03-15 2007-11-06 Franco Wayne P Method for performing a non-invasive blood gas test
CN101438168B (zh) * 2006-03-24 2013-10-16 梅坦诺米克斯有限公司 预测糖尿病的工具和方法
EP2013619B1 (de) 2006-04-10 2017-10-11 Wisconsin Alumni Research Foundation Verfahren zur verwendung menschlicher embryonischer stammzellen zur beurteilung der toxizität pharmazeutischer verbindungen und anderer chemikalien
US8137977B2 (en) * 2006-04-24 2012-03-20 Children's Hospital & Research Center At Oakland Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
US8498879B2 (en) * 2006-04-27 2013-07-30 Wellstat Vaccines, Llc Automated systems and methods for obtaining, storing, processing and utilizing immunologic information of individuals and populations for various uses
WO2007144467A1 (en) * 2006-06-12 2007-12-21 Zora Biosciences Oy Diagnostic method for myopathy
US20100233724A1 (en) * 2006-08-08 2010-09-16 Watkins Steven M Markers of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash) and methods of use thereof
US9255348B2 (en) 2006-08-25 2016-02-09 The Trustees Of Columbia University In The City Of New York Systems and methods for biodosimetry with biochip using gene expression signatures
US7822249B2 (en) * 2006-08-25 2010-10-26 The Trustees Of Columbia University In The City Of New York Systems and methods for high-throughput radiation biodosimetry
EP1923806A1 (de) * 2006-11-14 2008-05-21 Metanomics GmbH Schnelle, metabolomische Analyse und System dafür
CA2721129A1 (en) * 2007-04-12 2008-10-23 Carolyn Marie Slupsky Urine based detection of a disease state caused or effected by pneumococcal infection
CN102105797A (zh) * 2008-05-28 2011-06-22 巴斯夫欧洲公司 用于评估过氧化物酶体增殖的工具和方法
WO2010033816A1 (en) * 2008-09-18 2010-03-25 Ingenix, Inc. Apparatus, system and method for graphically displaying natural history of disease progression
CA2793216C (en) 2010-03-22 2020-01-07 Stemina Biomarker Discovery, Inc. Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
DK2385374T4 (en) 2010-05-05 2018-04-30 Zora Biosciences Oy LIPIDOMICS BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE
JP5662060B2 (ja) 2010-06-04 2015-01-28 学校法人帝京大学 検出方法
CN108445241B (zh) 2010-06-20 2021-11-02 佐拉生物科学公司 用于鉴定高风险冠状动脉疾病患者的脂质组学标志
US20120078521A1 (en) * 2010-09-27 2012-03-29 General Electric Company Apparatus, system and methods for assessing drug efficacy using holistic analysis and visualization of pharmacological data
US9541565B2 (en) 2011-04-08 2017-01-10 Zora Biosciences Oy Biomarkers for sensitive detection of statin-induced muscle toxicity
KR20140090448A (ko) * 2013-01-09 2014-07-17 한국전자통신연구원 의료 관리 서버 및 그것의 의료 관리 방법
US10175256B2 (en) 2013-09-26 2019-01-08 National University Of Singapore Compositions and methods utilizing lysophosphatidylcholine scaffolds
EP3129909B1 (de) * 2014-04-08 2020-09-16 Metabolon, Inc. Kleinmolekülige biochemische profilierung von personen zur krankheitsdiagnose und gesundheitsbeurteilung
CN105353607B (zh) * 2015-11-26 2017-10-27 江南大学 一种由数据差异驱动的间歇过程自学习动态优化方法
US11036779B2 (en) * 2018-04-23 2021-06-15 Verso Biosciences, Inc. Data analytics systems and methods
JP2020180826A (ja) * 2019-04-24 2020-11-05 株式会社島津製作所 分析データ解析システム
CN112986425B (zh) * 2021-02-09 2023-07-04 首都医科大学 Pm2.5对脂质代谢影响的检测标志物及应用
CN115112776B (zh) * 2021-03-18 2023-07-04 中国科学院大连化学物理研究所 联合标志物及在诊断心房颤动中应用及诊断试剂或试剂盒
CN115774059A (zh) * 2021-09-07 2023-03-10 中国科学院深圳先进技术研究院 一种阿尔兹海默症生物标志物及其筛选方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873726A (en) * 1968-02-14 1975-03-25 Ethyl Corp Method and composition for reducing plasma lipid levels
US3847550A (en) * 1973-03-27 1974-11-12 Atomic Energy Commission Differential chromatographic method
US5075101A (en) * 1990-04-10 1991-12-24 Siguel Edward N Method for diagnosis of fatty acid or lipid abnormalities
US5706603A (en) * 1990-11-16 1998-01-13 E. I. Du Pont De Nemours And Company Production method for corn with enhanced quality grain traits
US5773300A (en) * 1995-05-18 1998-06-30 Cell Therapeutics, Inc. Neoplasia diagnostic method
NZ325814A (en) * 1995-12-21 2000-10-27 Nestle Sa Process for immortalizing human skin cell lines and a serum-free medium
US5952235A (en) * 1997-04-14 1999-09-14 Case Western Reserve University Detection of teratogen exposure
US6308170B1 (en) * 1997-07-25 2001-10-23 Affymetrix Inc. Gene expression and evaluation system
AU9198298A (en) * 1997-08-15 1999-03-08 Affymetrix, Inc. Polymorphism detection utilizing clustering analysis
US6222911B1 (en) * 1998-08-05 2001-04-24 Nortel Networks Limited Programmable access carrier selection terminal
US6185561B1 (en) * 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
WO2000051054A1 (en) * 1999-02-26 2000-08-31 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
AU2002233310A1 (en) * 2001-01-18 2002-07-30 Basf Aktiengesellschaft Method for metabolic profiling

Also Published As

Publication number Publication date
WO2003005628A3 (en) 2003-11-06
AU2002320316A1 (en) 2003-01-21
EP1417629B1 (de) 2008-02-20
US20110172926A1 (en) 2011-07-14
US20040143461A1 (en) 2004-07-22
EP1417629A4 (de) 2005-08-17
WO2003005628A2 (en) 2003-01-16
CA2452660A1 (en) 2003-01-16
EP1417629A2 (de) 2004-05-12
DE60225145D1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
ATE386986T1 (de) Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten
Wathan et al. Online access to quantitative data resources
Asch Rebuilding Dresden.
Kumar CAMBODIA'S FIRST VISUAL ARTS OPEN.
Ellyatt Teaching from the Soul.
Barrons et al. 8th KLOA Conference Report: Our Impression.
Joudene Future forward.
Ellemor et al. Recently completed doctorates in social and cultural geography.
Randall International Interest in CMA/CFM Programs Grows.
Awarded MONTESSORI MILESTONES
Blackburn et al. Television PSAs.
Tomar Remarks on Receiving the Distinguished Service Award.
Walter Ebrary adds to services.
Parushev Evangelical Scholars address Public Theology.
Keeney GNOMIC WORKS.
Kilpatrick 39^" NORTH AMERICAN MOOSE CONFERENCE AND WORKSHOP JACKSON HOLE, WYOMING 18-22 MAY 2003
Goodwine Ocean County Library Receives BlueClaws Grant.
Shockley The Whole Musician: Making Music Last a Lifetime.
Povell Nancy McCormick Rambusch: A Reflection.
Purnell Futures in Geographical Education.
Watts Sign Here, Please.
Smith Implementing the 14-19 reforms.
Wilcox et al. Sharing good practice
Edwards et al. Z's Gift.
Antin Some Historical Takes.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties